相关实验视频

Updated: Jan 16, 2026

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique

Published on: April 1, 2022

对部的抗生素治疗是否会降低囊手术的风险? 一个回顾性研究研究

Amine Antonin Alam¹, Nadia Fathallah¹, Manuel Aubert¹

¹Department of Medical & Surgical Proctology, Léopold-Bellan Institute, Saint Joseph's Hospital, Paris, France.

Clinics and research in hepatology and gastroenterology

|October 5, 2025

概括

首次通过切口治疗近腹的复发率为18%. 切口后的抗生素可能会降低患有近腹的患者的复发风险,但需要进一步的试验.

科学领域:

产卵科产卵科是指产卵科.
外科胃肠道外科手术

背景情况:

第一次围腹的治疗缺乏共识.
虽然有些人主张进行系统的囊调查,但其他人则赞成简单的切口,因为复发率低.
切口后抗生素治疗的作用也在争论中.

研究的目的:

评估该部门对第一个周腹管理的方法.
确定初始治疗后复发的预测因素.

主要方法:

在2019年治疗的第一个近腹的109名患者的回顾性研究.
治疗包括在局部麻醉下切口,有或没有切口后的抗生素.
复发定义为新的腹或的开口;主要结局是囊手术或复发.

主要成果:

在~30个月的随访期间,仅用切口治疗的患者中观察到18%的复发率.
吸烟和缺少切口后抗生素与复发风险增加有关.
在复发和性别,年龄,BMI,糖尿病,克罗恩病,艾滋病毒,NSAID使用或部位置之间没有发现显著的关联.

结论:

41%的患者接受了切口治疗,因为第一次周腹没有出现复发.
切口后的抗生素治疗似乎可以降低复发的可能性.
随机试验是必要的,以确认这些发现,并确定最佳的抗生素方案.

关键词:

门的塞.抗生素治疗是一种抗生素治疗.周边腹是什么意思?周边腹是什么意思?复发情况复发情况

更多相关视频

Reverse Needle Continuous Suture of the Pancreatic Duct to Jejunal Mucosal Pancreaticointestinal Anastomosis in Laparoscopic Pancreaticoduodenectomy

Reverse Needle Continuous Suture of the Pancreatic Duct to Jejunal Mucosal Pancreaticointestinal Anastomosis in Laparoscopic Pancreaticoduodenectomy

Published on: August 29, 2025

相关概念视频

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...